BloombergSen Inc. Buys 71,949 Shares of Express Scripts Holding Co. (ESRX)
BloombergSen Inc. increased its stake in Express Scripts Holding Co. (NASDAQ:ESRX) by 5.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,396,497 shares of the company’s stock after buying an additional 71,949 shares during the period. Express Scripts Holding makes up about 11.2% of BloombergSen Inc.’s holdings, making the stock its 5th largest position. BloombergSen Inc. owned about 0.22% of Express Scripts Holding worth $105,854,000 as of its most recent filing with the SEC.
A number of other hedge funds also recently added to or reduced their stakes in ESRX. Oakworth Capital Inc. raised its stake in Express Scripts Holding by 966.7% in the second quarter. Oakworth Capital Inc. now owns 1,792 shares of the company’s stock valued at $136,000 after buying an additional 1,624 shares in the last quarter. Alpha Windward LLC raised its stake in Express Scripts Holding by 30.7% in the second quarter. Alpha Windward LLC now owns 1,988 shares of the company’s stock valued at $151,000 after buying an additional 467 shares in the last quarter. Community Trust & Investment Co. acquired a new stake in Express Scripts Holding during the second quarter valued at about $203,000. Northstar Group Inc. acquired a new stake in Express Scripts Holding during the second quarter valued at about $204,000. Finally, Agran Libbie acquired a new stake in Express Scripts Holding during the second quarter valued at about $205,000. Institutional investors and hedge funds own 88.52% of the company’s stock.
Shares of Express Scripts Holding Co. (NASDAQ:ESRX) traded down 0.07% on Tuesday, reaching $69.91. The company had a trading volume of 2,133,836 shares. The company’s 50-day moving average is $72.31 and its 200-day moving average is $73.75. The company has a market capitalization of $44.06 billion, a PE ratio of 17.27 and a beta of 1.16. Express Scripts Holding Co. has a one year low of $65.55 and a one year high of $89.20.
Express Scripts Holding (NASDAQ:ESRX) last issued its earnings results on Monday, July 25th. The company reported $1.57 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.57. Express Scripts Holding had a net margin of 2.64% and a return on equity of 23.98%. The business had revenue of $25.20 billion for the quarter, compared to analysts’ expectations of $25.42 billion. During the same quarter in the previous year, the firm posted $1.44 EPS. The business’s revenue for the quarter was down .9% compared to the same quarter last year. Equities research analysts predict that Express Scripts Holding Co. will post $6.36 earnings per share for the current year.
A number of equities analysts have recently weighed in on ESRX shares. Zacks Investment Research upgraded Express Scripts Holding from a “hold” rating to a “buy” rating and set a $85.00 target price on the stock in a research note on Tuesday, June 7th. Jefferies Group reiterated a “buy” rating on shares of Express Scripts Holding in a research note on Monday, July 4th. Credit Suisse Group AG reiterated a “buy” rating on shares of Express Scripts Holding in a research note on Monday, June 27th. Morgan Stanley reiterated a “hold” rating on shares of Express Scripts Holding in a research note on Monday, June 6th. Finally, Leerink Swann reiterated a “market perform” rating and set a $80.00 target price on shares of Express Scripts Holding in a research note on Thursday, September 1st. Three equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and eight have issued a buy rating to the company’s stock. Express Scripts Holding currently has an average rating of “Hold” and a consensus price target of $82.05.
In other news, Director Woodrow A. Myers, Jr. sold 12,036 shares of the company’s stock in a transaction on Wednesday, September 14th. The shares were sold at an average price of $70.40, for a total value of $847,334.40. Following the transaction, the director now owns 14,918 shares of the company’s stock, valued at $1,050,227.20. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, VP Christopher A. Mcginnis sold 1,785 shares of the company’s stock in a transaction on Monday, September 12th. The stock was sold at an average price of $70.77, for a total transaction of $126,324.45. Following the completion of the transaction, the vice president now directly owns 4,955 shares in the company, valued at approximately $350,665.35. The disclosure for this sale can be found here. 0.54% of the stock is currently owned by insiders.
About Express Scripts Holding
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Stock Ratings for Express Scripts Holding Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Co. and related stocks with our FREE daily email newsletter.